IMKURAQ Animal Health inspires to be a leader in developing new differentiated products to control diseases of shrimp. IMKURAQ provides a range of state-of- the-art aquaculture products to support the rapidly growing commercial shrimp feed supplements interests in this field. The company capabilities are to increase the speed and efficiency of progressing products to control vibriosis, EHP in pond and prevent spread of virus in pond during culture.
IMKURAQ utilizes a truly integrated approach to develop products by utilizing expertise of its sister company Imkuraq Therapeutics and in collaboration with IgY Immunologix. Imkuraq Therapeutics is a Singapore entity with mandate to develop Pharmaceuticals new drug candidate. Imkuraq Therapeutics has developed innovative product designed with disease biology understanding. IgY Immunologix is an IgY antibody technology company which has specialization for developing therapeutic and diagnostic antibodies for veterinary and aquaculture diseases.